Clinical & Diagnostic
AriBio Secures EMA Approval for Pivotal POLARIS-AD Alzheimer's Trial, Aligning with FDA and MHRA
AriBio Co., Ltd. (AriBio) announced authorisation from the European Medicines Agency (EMA) for POLARIS-AD (AR1001-ADP3-US01), a global, phase 3, early Alzh...
April 30, 2024 | News
C₂N Diagnostics Partners with Mediford Corporation to Expand Alzheimer's Research Services in Japan
-C₂N Diagnostics, LLC (“C2N”), a specialty diagnostics company with a vision to bring Clarity Through Innovation®, today announced a part...
April 29, 2024 | News
Fosun Pharma's Artemisinin Medicines Boost Malaria Fight in Africa
Accelerating the fight against malaria for a more equitable world. WHO stated that malaria not only continues to directly endanger health and cost lives, b...
April 29, 2024 | News
PolyU Partners with ZEISS Vision Care to Advance Global Myopia Control
The Hong Kong Polytechnic University (PolyU) is partnering with ZEISS Vision Care, one of the world's leading manufacturers of eyeglass lenses and ophthalm...
April 26, 2024 | News
Hyundai Bioscience Launches Clinical Trials for Innovative Niclosamide-Based Cancer Drug
Clinical trials of Niclosamide-based oral metabolic anticancer drug to commence for patients with difficult-to-treat cancers such as triple-negative...
April 23, 2024 | News
Aptamer Group Ships Innovative Optimer Delivery Vehicle for Liver Disease Treatment
Optimer delivery vehicle has been shipped to a pharma partner for external evaluation The specific delivery vehicle could generate new precision t...
April 22, 2024 | News
Hyundai Bioscience to Conduct Global Clinical Trials for Groundbreaking Dengue Treatment
Hyundai Bioscience CEO Oh Sang-gi, announced its plan to launch global clinical trials for a revolutionary treatment targeting all four serotypes of ...
April 22, 2024 | News
Eisai Launches Injectable Fycompa in Japan for Epilepsy Treatment
Eisai Co., Ltd. announcedthat the injection formulation of its in-house discovered antiepileptic drug (AED) Fycompa (perampanel hydrate) for intravenous (I...
April 19, 2024 | News
Gilead Sciences Invests US$4 Million in Global Fight Against Viral Hepatitis
Gilead Awards US$4 Million Globally (Excluding the United States) Through the Gilead ALL4LIVER Grant World Hepatitis Allianc...
April 16, 2024 | News
Serum Institute of India and Univercells Unite to Make Personalized Cancer Treatments Widely Available
Serum Institute of India (SII), the world’s largest vaccine manufacturer, has joined forces with Univercells, a Belgian biotech innovator,...
April 12, 2024 | News
Rising Prevalence of Inflammatory Bowel Disease in Developing Countries Signals Urgent Need for Innovative Treatments
IBD, or Inflammatory Bowel Disease, traditionally more prevalent in developed nations, is increasingly observed in developing regions like China....
April 11, 2024 | News
Transcenta and Agilent Collaborate on Companion Diagnostic for Advanced Gastric Cancer Trial
Transcenta Holding Limited ("Transcenta") (HKEX: 06628), a clinical stage biopharmaceutical company with fully-integrated capabilities in discovery, resear...
April 09, 2024 | News
Ractigen Therapeutics Launches Pioneering Phase I Clinical Trial for Bladder Cancer with First Patient Dosed in Collaboration with GenesisCare
Ractigen Therapeutics, a pioneer in small activating RNA (saRNA) therapeutics, achieved a major milestone with the first patient dosed in its First-in-huma...
April 04, 2024 | News
Invenra and Catalent Forge Partnership to Advance Cancer Treatment Innovations
Invenra Inc., an innovative leader in bispecific antibody technology, is pleased to announce a strategic collaboration with Catalent, a global Contract Dev...
April 03, 2024 | News
Most Read
- Lack of Regular Screening Fuels Rise in Late-Stage Breast Cancer in Hong Kong, New Report Reveals
- BIOCHINA 2025: Connecting Global Innovators with China's Leading Biotech Firms
- Leon Wyszkowski, President of Analytical Services, Discusses Thermo Fisher's Strategic Move: Expanding Bioanalytical Capabilities in Europe with New Sweden Lab
- The Role of Policy and Public Health Initiatives in Addressing Women's Cancer Care in Asia
- Redefining Patient Safety in the Age of Healthtech
Bio Jobs
- Avance Clinical Appoints Jessica Han as Director of Asian Operations, Strengthening Commitment to the Asian Market
- Bristol Myers Squibb Employees Cycle Coast-to-Coast to Raise $1 Million for Cancer Research
- Pfizer Australia Commits $150M to Upgrade Melbourne Facility, Bolstering Global Fight Against Antimicrobial Resistance
- SMi Systems Appoints Dr. Stefan Hamill as Vice President of Strategy to Drive Commercialisation and Growth
- Thermo Fisher Scientific Appoints William Hung as Senior Director and General Manager for Taiwan
- Cytiva Appoints Industry Veteran Pierre-Alain Ruffieux as Chief Operating Officer
News
Editor Picks
